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ALS is a neurodegenerative disorder that primarily affects motor neurons in the spinal cord, brain stem and cerebral cortex 1 . Frontotemporal dementia (FTD) is the second most common cause of presenile dementia. FTD is characterized by degeneration of the frontal and temporal lobes of the brain, which results in progressive changes in personality, behavior and language, with relative preservation of perception and memory 2, 3 . Recently, expansion of a noncoding hexanucleotide repeat in C9ORF72 was identified 4, 5 as a common cause of both ALS and FTD 6 .
Several potential mechanisms by which the C9ORF72 mutation might lead to neuronal degeneration have been proposed. A substantial reduction in transcript abundance has been observed in patients carrying expanded repeats 5, 7 , suggesting that haploinsufficiency could be involved in disease. The repeat expansion is associated with the formation of nuclear RNA foci, potentially indicating that alterations are occurring in RNA metabolism 4, 8 . Finally, ubiquitinated inclusions containing dipeptide proteins non-canonically translated from the GGGGCC repeats have been found following autopsy of C9ORF72 patients 9, 10 . However, whether one or more of these mechanisms are the cause of neuronal degeneration has not been resolved. Regardless of which molecular mechanism(s) are responsible for the mutation's negative effects, it remains to be determined whether this mutation acts primary in the neural subtypes subject to degeneration or through non-neuronal cell types, as has been suggested by studies of mutant SOD1. Moreover, the
The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD Using transgenic mice harboring a targeted LacZ insertion, we studied the expression pattern of the C9ORF72 mouse ortholog (3110043O21Rik). Unlike most genes that are mutated in amyotrophic lateral sclerosis (ALS), which are ubiquitously expressed, the C9ORF72 ortholog was most highly transcribed in the neuronal populations that are sensitive to degeneration in ALS and frontotemporal dementia. Thus, our results provide a potential explanation for the cell type specificity of neuronal degeneration caused by C9ORF72 mutations. normal physiological function of C9ORF72 and its expression pattern in the developing and adult nervous system have not been explored. As a first step toward understanding the function of C9ORF72 in development, normal brain function, and disease, we produced mice harboring a LacZ reporter gene targeted to the mouse ortholog of C9ORF72 and used them to study the gene's expression pattern 11 .
The C9ORF72 gene is located on the reverse strand of chromosome 9 (Chr 9: 27,546,544 -27,573,864) (Fig. 1a) . We found that the mouse 3110043O21Rik gene was located on the reverse strand of chromosome 4 (Chr4: 35,191,285-35,226,175) in a syntenic position, centromeric to Mob3b and Ifnk and telomeric to Lingo2 (Fig. 1b) . BlastN revealed >90% identity between the predicted human C9ORF72 and the mouse 311043O21Rik genes. Non-human primates, other mammals, Xenopus and zebrafish also possess apparent orthologs with 66-98% amino acid identity ( Fig. 1c and Supplementary Fig. 1 ). Only nine amino acids differed between the predicted protein sequences encoded by the mouse and human genes ( Supplementary  Fig. 2 ). In light of these findings, we will refer to the 311004O21Rik gene as the mouse C9ORF72 ortholog.
Analysis of predicted transcripts and expressed sequence tags (ESTs) revealed that the mouse and human orthologs also share similar predicted intron-exon structures (Supplementary Fig. 3 ). In humans, predicted isoform 1 and a rare EST did not include the site of the repeat expansion sequence, whereas isoforms 2 and 3 and several rare ESTs did. Predicted transcript isoforms 1 and 2 in mouse did not contain the location of the human repeat, whereas isoform 3 and relatively rare ESTs did. To experimentally determine the relative abundance of these isoforms, we performed RNA sequencing on mouse cortex and purified mouse and human embryonic stem cell-derived motor neurons. Among these transcripts, mouse isoform 1 was most highly expressed in mouse cortex and motor neurons, whereas isoforms 2, 3 and the predicted ESTs were far less abundant. In human motor neurons, isoform 1 was highly expressed, whereas human isoforms 2, 3 and ESTs were present at more modest levels ( Supplementary Fig. 3c-e) .
Comparative sequence analysis at the site of human repeat expansion revealed that the unexpanded GGGGCC repeat sequence is conserved in chimpanzees (Supplementary Fig. 4 ). This precise repeat sequence was not completely conserved in mouse. However, the CpG island in which the human repeat resides was highly conserved between chimpanzee and human (98% identity), and between human and mouse (58.3% identity). Thus, although the hexanucleotide repeat itself is not conserved outside of primates, it resides in a region that it is highly conserved between humans and mice and may therefore have a regulatory function.
Review of the Knockout Mouse Project database revealed that mouse embryonic stem cells (ESCs) harboring a LacZ insertion that replaced exons 2-6 of 311004O21Rik had been produced by gene targeting (Fig. 1d) 11 . Via standard methods, we produced chimeric mice that transmitted this mutant allele through the germline to offspring (Fig. 1d,e) . Using 7-9-week-old heterozygous mice, we studied the expression pattern of 311004O21Rik using X-galactosidase (X-gal) staining (Supplementary Table 1 and Supplementary  Fig. 5 ). In the brain, we found X-gal activity in the hippocampus, dentate gyrus, striatum, thalamus, brainstem nucleus, cerebellum and throughout the cortex (Fig. 2a-e) . We did not detect X-gal staining in white matter regions such as the corpus callosum ( Supplementary  Fig. 5 ). In the spinal cord, X-gal activity was distributed throughout the gray matter, with the highest levels being observed in the ventral horn (Fig. 2f,g ). Outside the CNS, the tibialis anterior muscle, heart, lung, liver and kidney were X-gal negative (Fig. 2h,i and Supplementary Fig. 5 ). The testis and germinal centers in the spleen were X-gal positive (Fig. 2j,k) .
To determine the identity of X-gal-positive cells in the CNS, we performed co-imunnostaining with antibodies to β-galactosidase (β-gal) and antibodies that labeled relevant classes of neuronal and non-neuronal CNS cell type (Fig. 3) . We found that 128 of 130 β-gal + cells in layer V of the cortex expressed NeuN (98%) and that 120 of 195 (62%) of β-gal+ cells in layer V further co-stained with antibodies specific to CTIP2, a transcription factor that is selectively expressed in cortical spinal motor neurons and other projection neurons of layers V and VI (Fig. 3a,b) . In cortical layers II and III, 112 of 114 β-gal + cells expressed NeuN (98%), with 107 of 112 (96%) of these NeuN + cells further expressing CUX1, a transcription factor found in callosal projection neurons (Supplementary Fig. 6 ). Throughout the spinal cord, cells expressing β-gal uniformly expressed NeuN (111 of 115 cells, 97%), with a fraction in the ventral horn further co-labeling with antibody to ChAT, indicating that many of the cells were spinal motor neurons (65 of 115 cells, 57%; Fig. 3c and Supplementary  Fig. 7) . In contrast, spinal cord microglia, as identified by IBAI staining, and astrocytes, as identified by GFAP expression, were largely and entirely β-gal negative, respectively (Iba1, 7 of 172 cells, 4%; GFAP, 0 of 172 cells, 0%; Fig. 3d and Supplementary Fig. 8) .
To independently validate the expression pattern observed in LacZ reporter mice, we used fluorescent in situ hybridization with probes 
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targeting exons 2-6 of human C9ORF72 and the mouse ortholog 311004O21Rik. We found that many cells with a neuronal morphology were labeled in both the human and mouse spinal cord (Fig. 3e-j) . Labeled cells were predominantly observed in the ventral and lateral horns of the mouse and human spinal cord gray matter and absent from the white matter, a distribution identical to that of β-gal + cells observed in heterozygous mice. Expression data compiled from the Allen Brain Atlas confirmed the expression pattern for 311004O21Rik ( Supplementary  Figs. 9 and 10) 12 . We also carried out a developmental survey of X-gal activity and found that transcription of 311004O21Rik was undetectable during prenatal stages and became activated in an expression pattern similar to that found in the adult over the first 2 weeks of postnatal life (Supplementary Table 2 ).
Here we found that 3110043O21Rik is the mouse ortholog of human C9ORF72, which is highly conserved between vertebrate species. Using transgenic mice carrying a LacZ reporter at 311004O21Rik, we found that transcription was most abundant in the neuronal cells that are known to degenerate in ALS and FTD. In contrast, 311004O21Rik was largely absent or undetectable in microglia and astrocytes. Although the results from our reporter analyses are clear, it is important to note that one limitation of this approach is that post-transcriptional regulation of 311004O21Rik could alter the relative localization of the protein that it encodes. Our findings do not rule out low levels of 311004O21Rik expression in non-neuronal cell types, but they do seem to argue against the notion that C9ORF72 mutations act predominantly through non-cell autonomous mechanisms mediated by the glial environment to mediate neural degeneration. Regardless of whether C9ORF72 repeat expansions act in disease through a loss-of-function or gain-of-function mechanism, our studies of 311004O21Rik provide a potential explanation for the cell-type selectivity of neural degeneration in individuals harboring this mutation: the neuronal types most sensitive to ALS and FTD transcribe the highest levels of this gene.
MeThodS
Methods and any associated references are available in the online version of the paper. generation of c9oRF72 knock-in mice. Target vector was designed in the National Institutes of Health Knockout Mouse project 11 . Briefly, electroporation of C57BL/6N mouse ESCs with linearized plasmid DNA was carried out in electroporation cuvettes. Stable clones were selected in medium containing Geneticin. The ESCs were injected into C57BL/6 blastocysts to create chimeric mice, which were bred with C57BL/6 mice to generate heterozygous 311004O21Rik knockin mice. Postnatal day 60 male mice were used for these experiments unless otherwise mentioned. Up to five mice are housed in the same cage. All of the experimental protocols and procedures were approved by the Animal Committee of Harvard University.
genotyping. Genomic DNA from ear biopsies was lysed in lysis buffer with proteinase K at 60 °C for 12 h. The PCR contained primer set A (5′-ATCACGACGCGCTGTATC-3′ and 5′-ACATCGGGGAAATAATATCG-3′), which detect LacZ sequence, and primer set B (5′-CCATGCTTACTGGGGAA GTC-3′ and 5′-AAGAAAGCCTTCGTGACAGC-3′), which detect deleted exons 4 and 5. Genomic DNA and primers (50 nM each) were placed in standard Taq buffer supplemented with 1.25 units of Taq polymerase for 10 min at 94 °C. After enzymatic amplification for 35 cycles, the PCR products were resolved on 2% agarose gel in Tris acetate-EDTA buffer.
X-gal staining of tissues. Mice were anesthetized with avertin and perfusionfixed with 4% paraformaldehyde (by volume). Tissues were harvested and postfixed in 4% paraformaldehyde overnight at 4 °C, washed with phosphate-buffered saline (PBS), immersed in 30% sucrose (by volume) for 24 h at 4 °C, and frozen in optimal cutting temperature compound for sectioning using cryostat. Some of the specimens from CNS were washed with PBS and cut using vibratome. X-gal activity was assessed by incubating 10-50-µm-thick sections with LacZ staining solution (1.0 mg ml −1 of X-gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM MgCl 2 ) for 30 min to 12 h at 37 °C. The sections were examined and photographed with a Zeiss AX10.
